Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("tumour necrosis factor")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 629

  • Page / 26

Export

Selection :

  • and

Tumour necrosis factor-α converting enzyme (TACE) activity in human colonic epithelial cellsKIRKEGAARD, T; PEDERSEN, G; SAERMARK, T et al.Clinical and experimental immunology (Print). 2004, Vol 135, Num 1, pp 146-153, issn 0009-9104, 8 p.Article

Rho GTPases and the regulation of endothelial permeabilityWOJCIAK-STOTHARD, Beata; RIDLEY, Anne J.Vascular pharmacology. 2002, Vol 39, Num 4-5, pp 187-199, issn 1537-1891, 13 p.Article

Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritisSMITH, R; TARNER, I. H; HOLLENHORST, M et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 15, pp 1248-1257, issn 0969-7128, 10 p.Article

Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-α by inhibiting nuclear factor-κB activationPOSADAS, Inmaculada; DE RASA, Salvatore; TERENCIO, M. Carmen et al.British journal of pharmacology. 2003, Vol 138, Num 8, pp 1571-1579, issn 0007-1188, 9 p.Article

Serum tumour necrosis factor-α and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndromeRADHAKRISHNAN, V. V; SUMI, M. G; REUBEN, S et al.Acta neurologica scandinavica. 2004, Vol 109, Num 1, pp 71-74, issn 0001-6314, 4 p.Article

Cell cycle-specific effects of tumor necrosis factor = Effets spécifiques du cycle cellulaire du facteur de nécrose tumoraleDARZYNKIEWICZ, Z; WILLIAMSON, B; CARSWELL, E. A et al.Cancer research (Baltimore). 1984, Vol 44, Num 1, pp 83-90, issn 0008-5472Article

Effect of tumour necrosis factor-α and interleukin 1β on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitroWIMALASUNDERA, R; FEXBY, S; REGAN, L et al.British journal of pharmacology. 2003, Vol 138, Num 7, pp 1285-1294, issn 0007-1188, 10 p.Article

RESEARCH ON THE PRODUCTION SITE OF TUMOR NECROSIS FACTOR (TNF)SATOMI N; HARANAKA K; KUNII O et al.1981; JPN. J. EXP. MED.; ISSN 0021-5031; JPN; DA. 1981; VOL. 51; NO 6; PP. 317-322; BIBL. 14 REF.Article

Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopeniaZHU, Xiao-Juan; YAN SHI; FENG ZHANG et al.British journal of haematology. 2014, Vol 166, Num 5, pp 783-791, issn 0007-1048, 9 p.Article

Effects of sodium chloride on the production of bioactive exopolysaccharides in submerged cultures of Phellinus linteusSHU, Chin-Hang; HSU, Hui-Ju.Journal of chemical technology and biotechnology (1986). 2008, Vol 83, Num 5, pp 618-624, issn 0268-2575, 7 p.Article

TUMOUR-NECROSIS FACTOR FROM THE RABBIT. V: SYNTHESIS IN VITRO BY MONONUCLEAR PHAGOCYTES FROM VARIOUS TISSUES OF NORMAL AND BCG-INJECTED RABBITSMATTHEWS N.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 3; PP. 418-424; BIBL. 8 REF.Article

Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitisIKEZAWA-SUZUKI, Ikuyo; SHIMADA, Yasuko; TAI, Hideaki et al.Journal of clinical periodontology. 2008, Vol 35, Num 11, pp 961-968, issn 0303-6979, 8 p.Article

Association between cigarette smoking and release of tumour necrosis factor α and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritisGLOSSOP, J. R; DAWES, P. T; MATTEY, D. L et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 10, pp 1223-1229, issn 1462-0324, 7 p.Article

Effects of culture temperature on the production of bioactive polysaccharides by Agaricus blazei in batch culturesSHU, Chin-Hang; LIN, Ko-Jung; WEN, Bor-Jiun et al.Journal of chemical technology and biotechnology (1986). 2007, Vol 82, Num 9, pp 831-836, issn 0268-2575, 6 p.Article

Psoriasis: from pathogenesis to novel therapeutic approachesMONTELEONE, Giovanni; PALLONE, Francesco; MACDONALD, Thomas T et al.Clinical science (1979). 2011, Vol 120, Num 1-2, pp 1-11, issn 0143-5221, 11 p.Article

Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials : a survey of power considerationsYAZICI, Y; ADLER, N. M; YAZICI, H et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 7, pp 1054-1057, issn 1462-0324, 4 p.Article

Heterophile interference accounts for method-specific dsDNA antibodies in patients receiving anti-TNF treatmentALSHEKAILI, Jalila; LI, Candice; COOK, Matthew C et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 5, pp 891-897, issn 1462-0324, 7 p.Article

Immunogénicité des anti-TNFαSARAUX, A.La Lettre du rhumatologue. 2007, Num 336, pp 3-4, issn 0761-5027, 2 p., SUPArticle

Comparison of in vitro cell cytotoxic assays for tumor necrosis factorFLICK, D. A; GIFFORD, G. E.Journal of immunological methods. 1984, Vol 68, Num 1-2, pp 167-175, issn 0022-1759Article

Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparumHAIDARIS, C. G; HAYNES, J. D; MELTZER, M. S et al.Infection and immunity. 1983, Vol 42, Num 1, pp 385-393, issn 0019-9567Article

INHIBITION OF L-CELL GROWTH IN AGAROSE (ILGA): A SIMPLE INEXPENSIVE METHOD FOR THE DETECTION AND QUANTITATION OF FACTORS INHIBITING TUMOR CELL GROWTH = INHIBITION DE LA CROISSANCE DES CELLULES L EN AGAROSE (ILGA): UNE METHODE SIMPLE ET PEU COUTEUSE POUR LA MISE EN EVIDENCE ET LE DOSAGE DE FACTEURS INHIBANT LA CROISSANCE DES CELLULES TUMORALESPRINCE HE; ANDERSON WL; TOMASI TB et al.1982; J. IMMUNOL. METHODS; ISSN 0022-1759; NLD; DA. 1982; VOL. 48; NO 3; PP. 367-372; BIBL. 7 REF.Article

Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral discHOYLAND, J. A; LE MAITRE, C; FREEMONT, A. J et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 6, pp 809-814, issn 1462-0324, 6 p.Article

Cytotoxic effect of tumor necrosis factor on human lymphocytes and specific binding of the factor to the target cellsUMEDA, T; HARA, T; NIIJIMA, T et al.Cellular and molecular biology. 1983, Vol 29, Num 5, pp 349-352, issn 0145-5680Article

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor a antagonists and disease-modifying antirheumatic drugsCURTIS, J. R; MARTIN, C; SAAG, K. G et al.Arthritis care and research. 2007, Vol 57, Num 2, pp 343-346, issn 0893-7524, 4 p.Article

Psoriasis induced by anti-tumor necrosis factor therapy : A class effect?RICHETTE, Pascal; VIGUIER, Manuelle; BACHELEZ, Hervé et al.Journal of rheumatology. 2007, Vol 34, Num 2, pp 438-439, issn 0315-162X, 2 p.Article

  • Page / 26